Ligne de temps

Frédéric Tangy
Chercheur(euse) Permanent(e)
09 mars 2024
publication

Comparative analysis of rabies pathogenic and vaccine strains detection by RIG-I-like receptors.

Lire plus
05 févr. 2024
team

Laboratoire commun Institut Pasteur-Oncovita

Lire plus
19 déc. 2023
publication

NDP52 mediates an antiviral response to hepatitis B virus infection through Rab9-dependent lysosomal degradation pathway.

Lire plus
30 sept. 2023
publication

Novel Antiviral Molecules against Ebola Virus Infection.

Lire plus
11 mars 2023
publication

Rapid protection induced by a single-shot Lassa vaccine in male cynomolgus monkeys

Lire plus
15 juil. 2022
publication

Y RNAs are conserved endogenous RIG-I ligands across RNA virus infection and are targeted by HIV-1

Lire plus
22 déc. 2021
publication

sgDI-tector: defective interfering viral genome bioinformatics for detection of coronavirus subgenomic RNAs

Lire plus
14 déc. 2021
project

Towards understanding of immunostimulatory properties of SARS-CoV-2 RNAs

Lire plus
01 nov. 2021
publication

A live measles-vectored COVID-19 vaccine induces strong immunity and protection from SARS-CoV-2 challenge in mice and hamsters

Lire plus
09 sept. 2021
course

MOOC Viruses and Human Cancers

Lire plus
01 sept. 2021
publication

Discovery of genes that modulate flavivirus replication in an interferon-dependent manner

Lire plus
09 juin 2021
publication

A single-shot Lassa vaccine induces long-term immunity and protects cynomolgus monkeys against heterologous strains.

Lire plus
27 janv. 2021
publication

Proteomic Analysis Uncovers Measles Virus Protein C Interaction With p65–iASPP Protein Complex

Lire plus
27 oct. 2020
publication

Retinoic Acid Inducible Gene I and Protein Kinase R, but Not Stress Granules, Mediate the Proinflammatory Response to Yellow Fever Virus

Lire plus
15 janv. 2019
publication

Uncovering Flavivirus Host Dependency Factors through a Genome-Wide Gain-of-Function Screen.

Lire plus
01 oct. 2018
publication

DI-tector: defective interfering viral genomes’ detector for next-generation sequencing data.

Lire plus
10 juil. 2018
publication

RIG-I Recognizes the 5′ Region of Dengue and Zika Virus Genomes.

Lire plus
25 sept. 2017
event

10-Year Anniversary of the Institut Pasteur International Vaccinology Course

Lire plus
21 sept. 2017
event

2017 INTERNATIONAL SOCIETY FOR VACCINES ANNUAL CONGRESS at INSTITUT PASTEUR

Lire plus
14 août 2017
publication

Original chemical series of pyrimidine biosynthesis inhibitors that boost the antiviral interferon response

Lire plus
24 avr. 2017
event

GPF Vaccinology day

Lire plus
27 févr. 2017
event

VIROLOGY DEPARTMENT SEMINAR

Lire plus
18 oct. 2016
publication

Oncolytic measles virus induces tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated cytotoxicity by human myeloid and plasmacytoid dendritic cells.

Lire plus
24 mars 2016
publication

Comparative analysis of viral RNA signatures on different RIG-I-like receptors

Lire plus
12 févr. 2016
project

Group for AIDS Research

Lire plus
08 oct. 2015
project

GPF Vaccinology Call 1: Open call for new ideas for cutting-edge science investigations in vaccinology.

Lire plus
08 oct. 2015
project

GPF Vaccinology Call 2: Accelerating Preclinical Development of Vaccine Candidates

Lire plus
07 oct. 2015
program_project

Grand Programme Fédérateur Vaccinologie

Lire plus
01 oct. 2015
patent

A dengue virus chimeric polyepitope composed of fragments of non-structural proteins and its use in an immunogenic composition against dengue virus infection (E14305984.8)

Lire plus
26 sept. 2015
project

Comics on vaccination

Lire plus
28 juil. 2015
project

Alkoxypyrazoles, inhibitors of dihydroorotate dehydrogenase (DHODH)

Lire plus
04 juil. 2015
project

Bivalent vaccines derived from measles vaccine

Lire plus
30 juin 2015
publication

Original 2-(3-Alkoxy-1H-pyrazol-1-yl)azines Inhibitors of Human Dihydroorotate Dehydrogenase (DHODH)

Lire plus
02 mars 2015
publication

Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial

Lire plus
06 janv. 2015
publication

Original 2-(3-alkoxy-1H-pyrazol-1-yl)pyrimidine derivatives as inhibitors of human dihydroorotate dehydrogenase (DHODH)

Lire plus
01 janv. 2015
publication

A field-proven yeast two-hybrid protocol used to identify coronavirus-host protein-protein interactions

Lire plus
23 déc. 2014
publication

Evidence for an intranasal immune response to human respiratory syncytial virus infection in cynomolgus macaques

Lire plus
29 août 2014
publication

Use of SLAM and PVRL4 and identification of pro-HB-EGF as cell entry receptors for wild type phocine distemper virus

Lire plus
05 mai 2014
publication

High-throughput screening for broad-spectrum chemical inhibitors of RNA viruses

Lire plus
28 janv. 2014
publication

Protection from SARS coronavirus conferred by live measles vaccine expressing the spike glycoprotein

Lire plus
27 janv. 2014
publication

Whole Pichia pastoris yeast expressing measles virus nucleoprotein as a production and delivery system to multimerize Plasmodium antigens.

Lire plus
17 oct. 2013
publication

Yellow fever vaccine attenuation revealed: loss of diversity

Lire plus
03 oct. 2013
publication

Inhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunity

Lire plus
30 sept. 2013
publication

Vaccines in development against West Nile virus

Lire plus
07 août 2013
publication

The Golgi protein ACBD3, an interactor for poliovirus protein 3A, modulates poliovirus replication

Lire plus
04 juin 2013
publication

A recombinant measles vaccine expressing chikungunya virus-like particles is strongly immunogenic and protects mice from lethal challenge with chikungunya virus

Lire plus
01 juin 2013
publication

Species-specific impact of the autophagy machinery on Chikungunya virus infection.

Lire plus
01 avr. 2013
publication

Identification of RNA partners of viral proteins in infected cells

Lire plus
28 mars 2013
publication

Antitumor Virotherapy by Attenuated Measles Virus (MV)

Lire plus
20 mars 2013
publication

On dihydroorotate dehydrogenases and their inhibitors and uses

Lire plus
14 janv. 2013
publication

The V protein of Tioman virus is incapable of blocking type I interferon signaling in human cells

Lire plus
13 déc. 2012
publication

RelAp43, a member of the NF-κB family involved in innate immune response against Lyssavirus infection

Lire plus
14 sept. 2012
publication

A phenotypic assay to identify Chikungunya virus inhibitors targeting the nonstructural protein nsP2

Lire plus
13 sept. 2012
publication

Human Tribbles 3 protects nuclear DNA from cytidine deamination by APOBEC3A

Lire plus
08 août 2012
publication

Comparative analysis of virus-host interactomes with a mammalian high-throughput protein complementation assay based on Gaussia princeps luciferase

Lire plus
02 mai 2012
publication

Measles vaccine expressing the secreted form of West Nile virus envelope glycoprotein induces protective immunity in squirrel monkeys, a new model of West Nile virus infection

Lire plus
02 mai 2012
publication

A human coronavirus responsible for the common cold massively kills dendritic cells but not monocytes

Lire plus
01 mars 2012
publication

Mapping of Chikungunya virus interactions with host proteins identified nsP2 as a highly connected viral component.

Lire plus
12 sept. 2011
publication

Proteomic analysis of virus-host interactions in an infectious context using recombinant viruses

Lire plus
03 sept. 2011
publication

A chimeric measles virus with a lentiviral envelope replicates exclusively in CD4+/CCR5+ cells

Lire plus
20 juil. 2011
publication

The interaction of flavivirus M protein with light chain Tctex-1 of human dynein plays a role in late stages of virus replication

Lire plus
09 sept. 2010
publication

Virus-host protein interactions in RNA viruses

Lire plus
03 août 2010
publication

Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses

Lire plus
14 avr. 2010
publication

Enhanced gene silencing in cells cured of persistent virus infection by RNA interference

Lire plus
11 nov. 2009
publication

Structure of the nucleoprotein binding domain of Mokola virus phosphoprotein

Lire plus
27 oct. 2009
publication

Study of human RIG-I polymorphisms identifies two variants with an opposite impact on the antiviral immune response

Lire plus
18 sept. 2009
publication

Differential regulation of type I interferon and epidermal growth factor pathways by a human Respirovirus virulence factor

Lire plus
17 juil. 2009
publication

NRP/Optineurin Cooperates with TAX1BP1 to potentiate the activation of NF-kappaB by human T-lymphotropic virus type 1 tax protein

Lire plus
22 juin 2009
publication

Polo-like kinase 1 (PLK1) regulates interferon (IFN) induction by MAVS

Lire plus
05 avr. 2009
publication

Live attenuated measles vaccine expressing HIV-1 Gag virus like particles covered with gp160DeltaV1V2 is strongly immunogenic

Lire plus
12 nov. 2008
publication

Inhibition of IFN-alpha/beta signaling by two discrete peptides within measles virus V protein that specifically bind STAT1 and STAT2

Lire plus
17 juin 2008
publication

Inhibition of Chikungunya virus infection in cultured human muscle cells by furin inhibitors: impairment of the maturation of the E2 surface glycoprotein

Lire plus
30 mai 2008
publication

Inversing the natural hydrogen bonding rule to selectively amplify GC-rich ADAR-edited RNAs

Lire plus
12 déc. 2007
publication

Pediatric measles vaccine expressing a dengue antigen induces durable serotype-specific neutralizing antibodies to dengue virus

Lire plus
14 sept. 2007
publication

Recombinant vector derived from live attenuated measles virus: potential for flavivirus vaccines

Lire plus
07 août 2007
publication

Measles virus V protein blocks Jak1-mediated phosphorylation of STAT1 to escape IFN-alpha/beta signaling

Lire plus
22 août 2005
publication

A recombinant live attenuated measles vaccine vector primes effective HLA-A0201-restricted cytotoxic T lymphocytes and broadly neutralizing antibodies against HIV-1 conserved epitopes

Lire plus
01 mai 2005
publication

A paediatric vaccination vector based on live attenuated measles vaccine

Lire plus
10 avr. 2005
publication

The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro

Lire plus
01 janv. 2005
publication

Live attenuated measles vaccine as a potential multivalent pediatric vaccination vector

Lire plus
15 déc. 2004
publication

A chimeric human T cell leukemia virus type I bearing a deltaR Moloney-murine leukemia virus envelope infects mice persistently and induces humoral and cellular immune responses.

Lire plus
10 déc. 2004
publication

Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis

Lire plus
01 janv. 2004
publication

A single injection of recombinant measles virus vaccines expressing human immunodeficiency virus (HIV) type 1 clade B envelope glycoproteins induces neutralizing antibodies and cellular immune responses to HIV

Lire plus
01 août 2002
publication

A chimeric human T-cell lymphotropic virus type 1 with the envelope glycoprotein of Moloney murine leukemia virus is infectious for murine cells

Lire plus